Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

News Conference News ESC 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

September 09, 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

News Conference News ESC Heart Failure 2025

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

May 20, 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

April 08, 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

March 30, 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

February 21, 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

October 28, 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

May 17, 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Debating the Role of T-TEER in the Sickest Patients

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

November 20, 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

October 27, 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

March 20, 2023

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

News Conference News PCR London Valves 2022

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

November 28, 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

November 11, 2022

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

News Conference News AHA 2022

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

November 01, 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

September 23, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.